MAPT and Alzheimer disease: Additionally, GSK3-β is causally linked with the amyloidogenesis, the abnormal tau hyperphosphorylation at multiple sites and with inflammatory activation, representing thus an important hub between diabetes mellitus (DM) and AD which is also regarded as Type 3 diabetes (T3D) [46,47].